Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-015433
Filing Date
2025-02-06
Accepted
2025-02-06 16:30:14
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6440
  Complete submission text file 0000950170-25-015433.txt   8001
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 395 OYSTER POINT BLVD. SUITE 217 SOUTH SAN FRANCISCO CA 94080
Business Address
Bender Jeremy (Reporting) CIK: 0001863107 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 25597827